Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

5 big analyst cuts: Coinbase gets another downgrade, Carvana cut at JPMorgan

Published 07/13/2023, 06:25 AM
© Reuters

Here is your Pro Recap of the biggest analyst cuts you may have missed since yesterday: downgrades at Coinbase Global, Carvana, Cisco, Silk Road Medical, and WW Grainger.

InvestingPro subscribers got this news before anyone else. Start your 7-day trial to get on board.

Coinbase Global earns third downgrade this month

Barclays downgraded Coinbase Global (NASDAQ:COIN) to Underweight from Equalweight with a price target of $70.00 (from $61.00). This represents the company’s third downgrade this month.

Despite the company's positive performance in revenues and costs in recent quarters, Barclays believes the current low volumes and depressed USDC market cap, coupled with regulatory uncertainties and a recent surge in share prices, leave few near-term catalysts for growth.

Shares fell more than 1% premarket today.

Carvana falls on JPMorgan downgrade

Carvana (NYSE:CVNA) shares fell more than 3% premarket after JPMorgan downgraded the company to Underweight from Neutral with a price target of $10.00, as reported in real time on InvestingPro.

The firm believes that the company’s valuation has disconnected from its fundamentals, noting that the recent debate on Carvana shares has centered on liquidity and its ability to navigate a potential recession and sustained weakness in the used car market, rather than focusing on long-term business model fundamentals.

Carvana saw a 9% surge in its shares yesterday, driven by a favorable inflation report and JMP Securities’ price target raise.

Cisco cut to Neutral at BofA

Cisco Systems (NASDAQ:CSCO) shares fell more than 2% yesterday after BofA Securities downgraded the company to Neutral from Buy with a price target of $56.00.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The firm expressed concern regarding the product revenue estimates for the second half of 2024 and the fiscal year 2025, suggesting that the consensus estimates appear overly optimistic.

2 more downgrades

Silk Road Medical (NASDAQ:SILK) earned two downgrades following the proposed decision by CMS, which resulted in a share price drop of more than 28% yesterday.

BofA Securities downgraded the company to Underperform from Buy with a price target of $28.00 (from $51.00), while JPMorgan downgraded to Neutral from Overweight with a price target of $28.00 (from $50.00).

WW Grainger (NYSE:GWW) shares fell more than 2%yesterday after UBS downgraded the company to Neutral from Buy with a price target of $820.00 (from $815.00).

According to the firm, it no longer perceives a low-risk opportunity for EPS upside and believes the recent re-rating has already accounted for a sustained higher level of market outgrowth.

Get ready to supercharge your investment strategy with our exclusive discounts.

Don't miss out on this limited-time opportunity to access cutting-edge tools, real-time market analysis, and expert insights. Join InvestingPro today and unlock your investing potential. Hurry, the Summer Sale won't last forever!

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.